GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
2024 Full Year Results - Media Release
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
GQG - Price-sensitive ASX Announcement
Full Release
Key Points
- Net flows of US$20.2 billion for the full year ended 2024
- Funds under management as at 31 December 2024 of US$153.0 billion
- 2024 Net revenue of US$760.4 million, an increase of 46.9% from 2023
- 2024 Net operating income of US$577.9 million, an increase of 50.4% from 2023
- Diluted earnings per share increased 52.3% from US$0.10 in 2023 to US$0.15 in 2024
- Board declares 4Q 2024 final dividend of US$0.0378 per share
- Expansion of the dividend payout ratio to 50% - 95% of distributable earnings approved
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
Dividend/Distribution - GQG
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
GQG Partners Inc. (GQG) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Financials |
$6,561 |
Appendix 4E and 2024 Annual Report
|
14 Feb 2025 8:23AM |
$2.370 |
$2.220 |
fallen by
6.33%
|
|
GQG - Price-sensitive ASX Announcement
Full Release
Key Points
- GQG Partners Inc. reported a 26.9% increase in total FUM to $153 billion by the end of 2024.
- Net revenue growth was 46.9%, totaling $760.4 million, with management fees making up 96.8% of revenue.
- All four primary investment strategies have consistently outperformed their respective benchmarks.
- GQG launched the Private Capital Solutions business and acquired interests in private equity investments.
- The company ranked first in net flows in the Australian Global Large Growth Category and second in Emerging Markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$222 |
Financial Report Form 8-K dated 13 February 2025
|
14 Feb 2025 8:23AM |
$2.760 |
$1.680 |
fallen by
39.13%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Fourth quarter commercial revenue of $18.4 million, up 30% year-over-year
- Full-year commercial revenue reached $64.0 million, a 29% increase
- Gross profit margin for Q4 was 87.6%
- FDA granted 510(k) clearance for Cohealyxâ„¢ on December 19, 2024
- FDA approved RECELL GO® mini on December 23, 2024
- Amended credit agreement with OrbiMed on February 13, 2025
- Projected 2025 commercial revenue expected between $100 to $106 million
- Aiming for GAAP profitability by Q4 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$222 |
AVITA Medical Q4 & FY 2024 Earnings Presentation
|
14 Feb 2025 8:23AM |
$2.760 |
$1.680 |
fallen by
39.13%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- AVITA Medical aims to be a leader in therapeutic acute wound care.
- RECELL facilitates quick wound healing and repigmentation.
- The company focuses on solutions for traumatic injuries and surgical repairs.
- Financial projections indicate a potential revenue growth in the burn treatment market.
- AVITA Medical's technologies are designed to enhance patient recovery outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$222 |
AVITA Medical Reports Q4 and FY2024 Financial Results
|
14 Feb 2025 8:22AM |
$2.760 |
$1.680 |
fallen by
39.13%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- Commercial revenue in Q4 2024 increased by approximately 30% to $18.4 million.
- Full-year 2024 commercial revenue reached $64.0 million, up 29% from 2023.
- Gross profit margin was 87.6% in Q4 2024 and 85.8% for the entire year.
- FDA granted approvals for RECELL GO mini and Cohealyx in December 2024.
- Net loss for Q4 2024 was $11.6 million, compared to a net loss of $7.1 million in Q4 2023.
- AVITA projects full-year 2025 commercial revenue of $100 to $106 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$690 |
Update - Notification of buy-back - FPR
|
14 Feb 2025 8:22AM |
$2.640 |
$3.110 |
risen by
17.80%
|
|
Generation Development Group Limited (GDG) ORDINARY FULLY PAID |
Financials |
$2,159 |
Ineligible shareholder letter
|
14 Feb 2025 8:22AM |
$4.870 |
$5.460 |
risen by
12.11%
|
|
Generation Development Group Limited (GDG) ORDINARY FULLY PAID |
Financials |
$2,159 |
Retail Entitlement Offer booklet
|
14 Feb 2025 8:21AM |
$4.870 |
$5.460 |
risen by
12.11%
|
|
Generation Development Group Limited (GDG) ORDINARY FULLY PAID |
Financials |
$2,159 |
Letter to eligible retail shareholders and entitlement form
|
14 Feb 2025 8:21AM |
$4.870 |
$5.460 |
risen by
12.11%
|
|
Generation Development Group Limited (GDG) ORDINARY FULLY PAID |
Financials |
$2,159 |
Application for quotation of securities - GDG
|
14 Feb 2025 8:21AM |
$4.870 |
$5.460 |
risen by
12.11%
|
|
WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,742 |
Update - Notification of buy-back - WEB
|
14 Feb 2025 8:20AM |
$5.080 |
$4.820 |
fallen by
5.12%
|
|
L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$1,887 |
Net Tangible Asset Backing
|
14 Feb 2025 8:20AM |
$2.800 |
$3.000 |
risen by
7.14%
|
|
Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$129 |
Update - Notification of buy-back - VVA
|
14 Feb 2025 8:20AM |
$1.460 |
$1.270 |
fallen by
13.01%
|
|
G8 Education Limited (GEM) ORDINARY FULLY PAID |
Consumer Discretionary |
$710 |
Update - Notification of buy-back - GEM
|
14 Feb 2025 8:20AM |
$1.355 |
$0.920 |
fallen by
32.10%
|
|
Everest Metals Corporation Ltd (EMC) ORDINARY FULLY PAID |
Materials |
$30 |
Gold recovery commences at Revere Reef Project
|
14 Feb 2025 8:20AM |
$0.160 |
$0.135 |
fallen by
15.63%
|
|
EMC - Price-sensitive ASX Announcement
Full Release
Key Points
- EMC achieved gold extraction at Revere Gold Project.
- Approximately 1.4 tonnes of gold concentrate produced.
- 1,700 tonnes of mineralized material processed.
- Gold extraction coincided with record high prices.
- Bulk sampling program projected to finalize by Q2 2025.
- Gekko Processing Plant effectively utilized for gold recovery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
BPM Minerals Limited (BPM) ORDINARY FULLY PAID |
Materials |
$4 |
Drilling Resumes at Claw Gold Project
|
14 Feb 2025 8:20AM |
$0.072 |
$0.045 |
fallen by
37.50%
|
|
BPM - Price-sensitive ASX Announcement
Full Release
Key Points
- 6,000m aircore drilling program launched at Claw Gold Project.
- Targeting extensions of known mineralisation over an 8km corridor.
- High-grade results reported at Louie Prospect.
- Significant intercepts include 25m @ 1.27 g/t Au.
- Claw Project located near Capricorn Metals' Mount Gibson Gold Project.
- Ongoing news flow expected from active drill campaigns.
- Further exploration to secure additional 20km of strike potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,678 |
Update - Notification of buy-back - ORA
|
14 Feb 2025 8:20AM |
$2.230 |
$2.090 |
fallen by
6.28%
|
|
Hamelin Gold Limited (HMG) ORDINARY FULLY PAID |
Materials |
$13 |
Drill Target Defined at Ularring Gold Project
|
14 Feb 2025 8:20AM |
$0.055 |
$0.067 |
risen by
21.82%
|
|
HMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Surface soil sampling has defined a discrete gold anomaly at the Ularring Gold Project.
- The project is located 130 km northwest of Kalgoorlie within the Eastern Goldfield Province.
- The anomaly extends over 500 meters in strike length.
- A sample from a quartz vein near the anomaly returned 7.9 g/t gold.
- An aircore drill program is planned to commence in March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Ironbark Capital Limited (IBC) ORDINARY FULLY PAID |
Financials |
$46 |
Update - Notification of buy-back - IBC
|
14 Feb 2025 8:20AM |
$0.455 |
$0.440 |
fallen by
3.30%
|
|
Magnetic Resources NL (MAU) ORDINARY FULLY PAID |
Materials |
$381 |
Investor Presentation - RIU Conference
|
14 Feb 2025 8:20AM |
$1.305 |
$1.420 |
risen by
8.81%
|
|
ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$12 |
Change of Director's Interest Notice - M Panaccio
|
14 Feb 2025 8:20AM |
$0.170 |
$0.110 |
fallen by
35.29%
|
|
Magnetic Resources NL (MAU) ORDINARY FULLY PAID |
Materials |
$381 |
Half Yearly Report and Accounts
|
14 Feb 2025 8:20AM |
$1.305 |
$1.420 |
risen by
8.81%
|
|
Fat Prophets Global Contrarian Fund Limited (FPC) ORDINARY FULLY PAID |
Financials |
$30 |
Update - Notification of buy-back - FPC
|
14 Feb 2025 8:20AM |
$0.980 |
$1.095 |
risen by
11.73%
|
|
Arcadium Lithium Plc (LTM) ORDINARY FULLY PAID |
Materials |
- |
Form 8-K
|
14 Feb 2025 8:19AM |
$9.180 |
$9.330 |
risen by
1.63%
|
|